Transderm scop and Emla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Transderm scop (scopolamine) and Emla (lidocaine; prilocaine). Common drug interactions include arthralgia among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Transderm scop and Emla. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Transderm scop?

Transderm scop has active ingredients of scopolamine. It is often used in motion sickness. eHealthMe is studying from 3,011 Transderm scop users. Check the latest studies of Transderm scop.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.

On Aug, 01, 2026

16 people who take Transderm scop and Emla together, and have interactions are studied.

Transderm scop and Emla drug interactions.

What are the common drug interactions of Transderm Scop and Emla, by gender? *:

female:

Arthralgia (joint pain)
Headache (pain in head)
Pain
Pain in extremity
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Arrhythmia (irregular heartbeat)
Asthenia (weakness)
Emotional distress
Hypoaesthesia (reduced sense of touch or sensation)

male:

Abdominal pain
Activated partial thromboplastin time prolonged
Malaise (a feeling of general discomfort or uneasiness)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Rectal haemorrhage (bleeding from anus)
Alanine aminotransferase increased
Blood bilirubin increased
International normalised ratio increased
Blood alkaline phosphatase increased
Aspartate aminotransferase increased

What are the common drug interactions of Transderm Scop and Emla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal pain
Activated partial thromboplastin time prolonged
Alanine aminotransferase increased
Blood bilirubin increased
International normalised ratio increased
Blood alkaline phosphatase increased
Aspartate aminotransferase increased
Fatigue (feeling of tiredness)
Gamma-glutamyltransferase increased
Hepatic steatosis (fatty liver disease)

20-29:

Arthralgia (joint pain)
Burning sensation
Catheter site infection (infection at the site of insertion)
Death
Dehydration (dryness resulting from the removal of water)
Flushing (the warm, red condition of human skin)
Headache (pain in head)
Hot flush (sudden feelings of heat)
Klebsiella infection
Malignant neoplasm progression (cancer tumour came back)

30-39:

Arrhythmia (irregular heartbeat)
Arthralgia (joint pain)
Asthenia (weakness)
Emotional distress
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Muscle spasms (muscle contraction)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Pain

40-49:

Alopecia (absence of hair from areas of the body)
Blood creatinine increased
Drug effect decreased
Flushing (the warm, red condition of human skin)
Local swelling (swelling at the site of some application of substance or injury)
Lung disorder (lung disease)
Viith nerve paralysis

50-59:

Breast cancer

60+:

n/a

What are the existing conditions these people have? *

Pain: 8 people, 50.00%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 37.50%
Seasonal Allergy (allergic condition due to certain season): 6 people, 37.50%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 25.00%
Iron Deficiency Anaemia: 4 people, 25.00%
Constipation: 4 people, 25.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 25.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 25.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Transderm scop and Emla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously